Roche halts lung cancer immunotherapy trial due to latest setback
Roche will halt a trial of a new immunotherapy for lung cancer after the drug failed to show benefits over Merck & Co’s established treatment Keytruda, casting further doubt on the promise of a drug pioneered by the Swiss company.
ENTRADAS POPULARES
Putin may discuss Ukraine peace deal with Trump
noviembre 22, 2024
Spain’s vice-president Ribera blames floods on climate change
noviembre 22, 2024
Storm lashes northwestern US, killing two people
noviembre 22, 2024
Iceland volcano erupts for tenth time in three years
noviembre 22, 2024
TRANSMISIÓN EN VIVO